Möller, VidarÖstholm-Balkhed, ÅseBerild, DagFredriksson, MatsGottfredsson, MagnusHolmbom, MartinJärvinen, AskoKristjansson, MarRydell, UlfSonksen, Ute WolffKolmos, Hans JoernHanberger, Håkan2021-06-222021-06-222021-08-03Möller, V, Östholm-Balkhed, Å, Berild, D, Fredriksson, M, Gottfredsson, M, Holmbom, M, Järvinen, A, Kristjansson, M, Rydell, U, Sonksen, U W, Kolmos, H J & Hanberger, H 2021, 'Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010-2018', Infectious Diseases, vol. 53, no. 8, pp. 607-618. https://doi.org/10.1080/23744235.2021.1910338http://hdl.handle.net/10138/331704Background The Nordic countries have comparable nationwide antibiotic resistance surveillance systems and individual antibiotic stewardship programmes. The aim of this study was to assess antibiotic resistance among major pathogens in relation to practice guidelines for hospital antibiotic treatment and antibiotic use in Nordic countries 2010-2018. Methods Antibiotic resistance among invasive isolates from 2010-2018 and aggregated antibiotic use were obtained from the European Centre for Disease Prevention and Control. Hospital practice guidelines were obtained from national or regional guidelines. Results Antibiotic resistance levels among Escherichia coli and Klebsiella pneumoniae were similar in all Nordic countries in 2018 and low compared to the European mean. Guidelines for acute pyelonephritis varied; 2nd generation cephalosporin (Finland), 3rd generation cephalosporins (Sweden, Norway), ampicillin with an aminoglycoside or aminoglycoside monotherapy (Denmark, Iceland and Norway). Corresponding guidelines for sepsis of unknown origin were 2nd (Finland) or 3rd (Sweden, Norway, Iceland) generation cephalosporins, carbapenems, (Sweden) combinations of penicillin with an aminoglycoside (Norway, Denmark), or piperacillin-tazobactam (all Nordic countries). Methicillin-resistant Staphylococcus aureus rates were 0-2% and empirical treatment with anti-MRSA antibiotics was not recommended in any country. Rates of penicillin non-susceptibility among Streptococcus pneumoniae were low (12engcc_by_nc_ndinfo:eu-repo/semantics/openAccessAntibiotic resistancepractice guidelines as topicantibiotic stewardshipNordic countriesINVASIVE STREPTOCOCCUS-PNEUMONIAESEPTIC SHOCKANTIMICROBIAL RESISTANCESEPSISTHERAPYDEFINITIONSSTEWARDSHIPBACTEREMIACLONALITYFINLANDGeneral medicine, internal medicine and other clinical medicineArticleopenAccess822f5144-2b9f-4d43-a524-e5d87ed5f578000648771100001